4:39 PM
 | 
Aug 11, 2010
 |  BC Extra  |  Company News

Alectos, Merck in discovery deal for AD

Alectos Therapeutics Inc. (Burnaby, B.C.) partnered with Merck & Co. Inc. (NYSE:MRK) to discover and develop compounds...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >